Expanded Alternatives of CRISPR–Cas9 Applications in Immunotherapy of Colorectal Cancer
R Arroyo-Olarte, A Mejía-Muñoz… - Molecular Diagnosis & …, 2024 - Springer
Immunotherapy for colorectal cancer (CRC) is limited to patients with advanced disease who
have already undergone first-line chemotherapy and whose tumors exhibit microsatellite …
have already undergone first-line chemotherapy and whose tumors exhibit microsatellite …